National Health Investors, Inc. (NHI)

National Health Investors Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Rental Revenue	271.6	257.05	249.23	217.7	271.05
Other Revenue	83.88	55.29	49.72	36.37	-1.55
Total Revenue	379.29	335.58	320.39	278.76	297.17
Revenue Growth (YoY	13.03%	4.74%	14.93%	-6.19%	-9.86%
Property Expenses	71.91	53.42	51.1	9.79	11.64
Selling, General & Administrative	29.53	21.79	19.82	25.32	19.34
Depreciation & Amortization	80.94	71.44	69.97	70.88	80.8
Other Operating Expenses	1.08	0.04	0.45	29.04	0.79
Total Operating Expenses	183.47	146.69	141.34	135.03	112.56
Operating Income	195.82	188.9	179.05	143.74	184.61
Interest Expense	-57.37	-59.9	-58.16	-44.92	-50.81
Other Non-Operating Income	-1.57	-	0.2	1.11	0.35
EBT Excluding Unusual Items	136.88	129	121.09	99.93	134.15
Gain (Loss) on Sale of Investments	-	6.26	-	-	-
Gain (Loss) on Sale of Assets	0.46	6.68	14.72	28.34	32.5
Asset Writedown	-	-0.65	-1.64	-51.56	-51.82
Other Unusual Items	3.45	-4.64	0.21	-11.22	-2.86
Pretax Income	140.79	136.64	134.38	65.5	111.97
Earnings From Continuing Operations	140.79	136.64	134.38	65.5	111.97
Minority Interest in Earnings	1.39	1.35	1.27	0.9	-0.16
Net Income	142.18	137.99	135.65	66.4	111.8
Preferred Dividends & Other Adjustments	0.2	0.12	0.06	-	-
Net Income to Common	141.98	137.87	135.6	66.4	111.8
Net Income Growth	3.04%	1.72%	104.29%	-40.61%	-39.61%
Basic Shares Outstanding	47	44	43	45	46
Diluted Shares Outstanding	47	44	43	45	46
Shares Change (YoY)	6.69%	1.64%	-3.14%	-2.04%	2.31%
EPS (Basic)	3.03	3.14	3.13	1.48	2.45
EPS (Diluted)	3.02	3.13	3.13	1.48	2.44
EPS Growth	-3.51%	0.15%	111.16%	-39.34%	-41.06%
Dividend Per Share	3.640	3.600	3.600	3.600	3.803
Dividend Growth	1.11%	-	-	-5.33%	-13.78%
Operating Margin	51.63%	56.29%	55.88%	51.56%	62.12%
Profit Margin	37.43%	41.08%	42.32%	23.82%	37.62%
EBITDA	276.77	260.34	249.02	214.62	265.41
EBITDA Margin	72.97%	77.58%	77.72%	76.99%	89.31%
D&A For Ebitda	80.94	71.44	69.97	70.88	80.8
EBIT	195.82	188.9	179.05	143.74	184.61
EBIT Margin	51.63%	56.29%	55.88%	51.56%	62.12%
Funds From Operations (FFO)	218.66	200.65	190.37	158.96	211.08
FFO Per Share	4.65	4.55	4.39	3.55	4.62
Adjusted Funds From Operations (AFFO)	218.66	200.65	190.37	158.96	211.08
AFFO Per Share	4.65	4.55	4.39	3.55	4.62
FFO Payout Ratio	77.61%	78.00%	82.07%	101.77%	86.65%
Revenue as Reported	375.63	335.18	319.84	278.19	298.72

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.

SEC Filings: 10-K · 10-Q